Aline Seger1, Alessandro Gulberti1,2, Eik Vettorazzi3, Hanna Braa1, Carsten Buhmann1, Christian Gerloff1, Wolfgang Hamel4, Christian K E Moll2, Monika Pötter-Nerger1. 1. Department of Neurology, Hamburg, University Medical Center Hamburg-Eppendorf, Germany. 2. Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 3. Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 4. Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Abstract
BACKGROUND: Gait disturbances and balance remain challenging issues in Parkinsonian patients (PD) with deep brain stimulation (DBS). Short pulse deep brain stimulation (spDBS) increases the therapeutic window in PD patients, yet the effect on gait and postural symptoms remains unknown. OBJECTIVE: We assessed the efficacy of spDBS compared to conventional DBS (cDBS) within the subthalamic nucleus (STN) on Parkinsonian gait. METHODS: The study was a single-centre, randomized, double-blind, clinical short-term trial. 20 PD patients were studied postoperatively in three different conditions (DBS stimulation switched off (off DBS), spDBS with 40μs pulse width, cDBS with 60μs pulse width) on regular medication. The primary endpoint was the relative difference of gait velocity at self-paced speed during quantitative gait analysis between stimulation conditions. Secondary endpoints were changes of further measures of quantitative gait analysis, Ziegler course, Berg balance scale, FOG questionnaire, MDS-UPDRS, PDQ-39, and HADS. Mixed-model analysis and post-hoc t-tests were performed. RESULTS: Both spDBS and cDBS improved gait velocity at self-paced speed compared to off DBS, however, there was no significant difference between both stimulation modes. Still, 40% of the patients preferred spDBS over cDBS subjectively. Both stimulation modes were equally effective in improving secondary endpoints of gait, balance, motor and non-motor performances. CONCLUSION: The use of spDBS and cDBS is equally effective in improving gait and balance in PD and might be beneficial in specified cohorts of PD patients.
BACKGROUND: Gait disturbances and balance remain challenging issues in Parkinsonian patients (PD) with deep brain stimulation (DBS). Short pulse deep brain stimulation (spDBS) increases the therapeutic window in PD patients, yet the effect on gait and postural symptoms remains unknown. OBJECTIVE: We assessed the efficacy of spDBS compared to conventional DBS (cDBS) within the subthalamic nucleus (STN) on Parkinsonian gait. METHODS: The study was a single-centre, randomized, double-blind, clinical short-term trial. 20 PD patients were studied postoperatively in three different conditions (DBS stimulation switched off (off DBS), spDBS with 40μs pulse width, cDBS with 60μs pulse width) on regular medication. The primary endpoint was the relative difference of gait velocity at self-paced speed during quantitative gait analysis between stimulation conditions. Secondary endpoints were changes of further measures of quantitative gait analysis, Ziegler course, Berg balance scale, FOG questionnaire, MDS-UPDRS, PDQ-39, and HADS. Mixed-model analysis and post-hoc t-tests were performed. RESULTS: Both spDBS and cDBS improved gait velocity at self-paced speed compared to off DBS, however, there was no significant difference between both stimulation modes. Still, 40% of the patients preferred spDBS over cDBS subjectively. Both stimulation modes were equally effective in improving secondary endpoints of gait, balance, motor and non-motor performances. CONCLUSION: The use of spDBS and cDBS is equally effective in improving gait and balance in PD and might be beneficial in specified cohorts of PD patients.
Entities:
Keywords:
Deep brain stimulation; Parkinson’s disease; freezing of gait; gait disorder; short pulse width; subthalamic nucleus
Authors: Marta Villadóniga; Lidia Cabañes-Martínez; Laura López-Viñas; Samira Fanjul; Marta Del Álamo; Ignacio Regidor Journal: J Clin Med Date: 2022-04-18 Impact factor: 4.964
Authors: Nicoló G Pozzi; Chiara Palmisano; Martin M Reich; Philip Capetian; Claudio Pacchetti; Jens Volkmann; Ioannis U Isaias Journal: Front Hum Neurosci Date: 2022-05-16 Impact factor: 3.473
Authors: Jan Niklas Petry-Schmelzer; Lisa M Schwarz; Hannah Jergas; Paul Reker; Julia K Steffen; Haidar S Dafsari; Juan Carlos Baldermann; Gereon R Fink; Veerle Visser-Vandewalle; Till A Dembek; Michael T Barbe Journal: J Parkinsons Dis Date: 2022 Impact factor: 5.520